The goal of this research program is to identify and develop selective small molecule inhibitors of p300 and explore their efficacy in understanding and treating these diseases. During this period, the collaborative team utilized the previously developed HTS-amenable assay to conduct the envisioned high-throughput screen for inhibitors of p300. Screening hits were identified and cherrypicked for validation, and compounds with verified activity are currently being characterized in a number of secondary assays.

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Translational Science
Department
Type
DUNS #
City
State
Country
Zip Code